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Poisoning, a subtype of physical injury, is an important hazard in children and youth. Individuals with 
ADHD may be at higher risk of poisoning. Here, we conducted a systematic review and meta-analysis 
to quantify this risk. Furthermore, since physical injuries, likely share causal mechanisms with those of 
poisoning, we compared the relative risk of poisoning and injuries pooling studies reporting both. As 
per our pre-registered protocol (PROSPERO ID CRD42017079911), we searched 114 databases through 
November 2017. From a pool of 826 potentially relevant references, screened independently by two 
researchers, nine studies (84,756 individuals with and 1,398,946 without the disorder) were retained. 
We pooled hazard and odds ratios using Robust Variance Estimation, a meta-analytic method aimed to 
deal with non-independence of outcomes. We found that ADHD is associated with a significantly higher 
risk of poisoning (Relative Risk = 3.14, 95% Confidence Interval = 2.23 to 4.42). Results also indicated 
that the relative risk of poisoning is significantly higher than that of physical injuries when comparing 
individuals with and without ADHD (Beta coefficient = 0.686, 95% Confidence Interval = 0.166 to 1.206). 
These findings should inform clinical guidelines and public health programs aimed to reduce physical 
risks in children/adolescents with ADHD.
Poisoning is defined by the World Health Organization as “an injury that results from being exposed to an exoge-
nous substance that causes cellular injury or death”1. Poisons can be inhaled, ingested, injected or absorbed. On a 
global scale, poisoning is estimated to cause 350,000 deaths every year, of which 45,000 refer to individuals under 
the age of twenty1, and, more generally, it leads to higher mortality and morbidity rates in this age group2–6.
Risk factors for poisonings include age and sex, among others. Being male is related to a higher poisoning risk 
across all age groups1,5. The relationship between age and risk of poisoning has a bimodal distribution with two 
peaks of highest risk between the ages of 1 and 4, as well as between 13 and 18 years of age1,5. Age is also associated 
with a change in the mechanism of poisoning: whereas most poisonings before the age of fourteen are uninten-
tional, the proportion of intentional poisonings increases dramatically from that age onward1,7. The majority of 
suicide intents in adolescents consist of intentional intoxications1,6, accounting for one third of total poisonings 
in that age range5.
Attention-deficit/hyperactivity disorder (ADHD) has a world-wide estimated prevalence of around 5%8, 
which makes it the most frequent neurodevelopmental disorder in children and adolescents. It is characterized 
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by inattentive and/or hyperactive- impulsive symptoms that have a negative impact on social9, academic10, and 
health domains11–13, and reduce the quality of life14. ADHD is approximately four times more common in boys 
than in girls. Pharmacological treatment, including psychostimulants (methylphenidate and amphetamines) and 
non-psychostimulants (e.g., atomoxetine, guanfacine), is an important component of the multimodal treatment 
of ADHD15. In addition, a high percentage of patients have comorbid disorders hence increasing the probability 
of patients being poly-medicated16.
A recent meta-analysis by our group has demonstrated that the risk of physical injuries is significantly higher 
in children and adolescents with ADHD compared to the typically developing population. Additionally, this 
risk is significantly reduced by the use of ADHD medications17. Therefore, a plausible hypothesis is that ADHD 
symptoms (inattention, hyperactivity and impulsivity) could lead to a similar increase in the risk of poisoning. 
Impulsivity might be an important factor, especially considering that it is significantly associated with suicide 
attempts, as shown in a recent meta-analysis18. Indeed, a recent systematic review on the relationship between 
ADHD and suicide concluded that there is a positive association between ADHD and suicidality in both sexes 
and in all age groups that was likely mediated by the presence of comorbid disorders19. Furthermore, individuals 
with ADHD frequently have more access to potentially harmful medications that many of them take either for 
the disorder or for its comorbidities.
Whereas a higher rate of poisoning in children and adolescents with ADHD in comparison with their typi-
cally developing peers has been reported in individual studies, the magnitude of the association is unclear20,21. 
Therefore, a meta-analysis quantifying the risk of poisoning in children/adolescents with ADHD is timely. 
Of note, the previous meta-analysis on the risk of physical injuries excluded studies that specifically analyzed 
the risk of poisoning17. To fill this gap and complement the previous meta-analysis, we conducted the present 
meta-analysis aimed to quantifying the pooled risk of poisoning in children/adolescents with ADHD compared 
to non-ADHD controls. A secondary aim was to compare the magnitude of the risk of unintentional physical 
injuries and poisoning from studies that reported both. We hypothesized that children and adolescents meeting 
criteria of ADHD would have significantly higher rates of poisoning compared to those without ADHD, and this 
increased probability of poisoning would be greater than that of physical injuries.
Results
Searches carried out in 114 databases (including three major bibliographic databases plus 111 additional resources 
from a database aggregator) in November 2017 led to 826 articles, whereas nine studies were included in the final 
stage of the systematic review and meta-analysis20–29. Articles that were considered possible candidates for inclu-
sion during the first screening stage but were later deemed ineligible when the full text was assessed are listed 
in Table S1, with reasons for exclusion (see Supplementary material). Multiple reports derived from the Taiwan 
Longitudinal Health Insurance Database (LHID) were treated as the same study20,25,30–32, similarly to the Clinical 
Practice Research Datalink and Hospital Episode Statistics (CPRD-HES) from the United Kingdom23,33. The full 
process of article search and selection is shown in the PRISMA flow diagram in Fig. 1. Details from the included 
studies are reported in Table 1 (overall description) and Table 2 (identification of poisoning). Outcome-level data 
extracted from each article on the risk of poisoning can be found in Table 3 (16 outcomes in total).
The origin of the studies was varied, comprising North-America, Europe, Asia and Australia. All studies but 
one21 were based on large epidemiological databases. More specifically, there were two regional22,28 and three 
national databases20,23,26, a nationally representative survey27, a population-based prospective cohort24, a study 
using administrative claims from a self-insured company29, and a case-control study using a hospital-based reg-
istry21. Therefore, all studies but two21,27 analyzed administrative databases not specifically designed for research 
purposes at their inception34. A strength of the included studies is that they tended to have large sample sizes 
(between 87 and 1,010,067; median 10,073; for the controls and between 16 and 37,650; median 3,685; for 
Figure 1. PRISMA flow diagram of record identification and study selection. *Four additional articles only 
reporting physical injuries for two of the included studies were also found.
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ADHD). The systematic review and meta-analysis pooled data from a total sample of 84,756 and 1,398,946 chil-
dren and adolescents with and without ADHD respectively.
Overall, poisoning cases were uncommon. The median number per study of poisoned individuals that suf-
fered from ADHD was 14 (range 2–184), whereas the median number per study of poisoned individuals who 
did not suffer from ADHD was 29 (range 3–3,882). Prevalence (per 1000) ranged between 3.5 and 60 (median 
16) in children and adolescents with ADHD and between 0.8 and 37.3 (median 4.8) in children and adolescents 
without ADHD.
The ranges of ages of poisoning were large in most cases. An exception was a study in which ADHD was 
diagnosed in school-age children but retrospectively considered the risk of poisoning during pre-school28. This 
is a probable cause for the much higher risk of poisoning in both the group with and without ADHD in this 
study. The retrospective nature of studies and the use of administrative databases were also related to the type of 
strategies used to identify cases with ADHD and to define poisoning. In the majority of studies, ADHD diagnosis 
was defined based on ICD codes at visit discharges20,23,25,28,29, by taking medications for ADHD22, or based on the 
combinations of the two. However, two studies24,27 used scales of symptoms and DSM criteria. Similarly, diagno-
ses of poisoning were defined based on ICD codes. Whereas most studies included poisoning from medicinal and 
non-medicinal origins, two studies21,25 only included poisoning from medicinal drugs. Specifically, one25 analyzed 
poisoning cases that were intentional in nature, which led to a much smaller prevalence of poisoning in in adhd 
and controls.
The main analysis, showing the relative risk (RR) of poisoning between adolescents with and without ADHD, 
included eleven outcomes derived from nine studies. Variation among effect sizes was important as they ranged 
between 1.2 and 7.98 (median 3.47). The overlap between confidence intervals (CIs) was small. The lower bound 
of the CI ranged between 0.5 and 3.58 (median 1.91) and the upper bound between 2.6 and 49.35 (median 5.64). 
All analyses were carried out using Robust Variance Estimation (RVE) to take into account dependence between 
outcomes. Individuals with ADHD had a significantly increased risk of poisoning compared to individuals 
Name Country Sample Type of study
N non-
ADHD N ADHD ADHD diagnosis
% Male 
ADHD
% Male 
Control
Medicated 
% Duration Age range Risk Measure
Brehaut22 Canada BCLHD Registry 1010067 16806 Administrative coding (medication) 81,6 50,9 100 >1 0–19 OR
CPRD-HES23,33 UK CPRD-HES Registry 291909c 15742c Administrative coding 84,6 50,7 44 >1 3–17 HR
Hariharan21 US Registry  (Case-control) 87 16
Administrative coding (medication and 
ICD-9) NR NR 45 NA 5–9 OR
Hurtig24 Finland NFBC Prospective cohort 5639
a 288d Clinical/Scales with threshold 66.1a 48.5a 0 >1 0–15 HR
LHID20,25,30–32 Taiwan LHID Registry 36850ac 3685ac Administrative coding 79.0ac 79.0ac 74.3ac >1 3–18 OR and HR
Lindemann26 Germany GEPARD Regystry 37650 37650 Administrative coding (medication and ICD-10) NR NR NR >1 3–17 HR
Rowe27 UK BCAMHS:99 Population-based survey 10073
b 365b DSM-IV NR NR NR >1 5–15 OR
Silva28 Australia MNS Registry 5363 8896 Administrative coding (ICD-9 and ICD-10) 78.3 78 100 >1 0–4 OR
Swensen29 US Registry 1308 1308 Administrative coding (Other ICD) 73.2 73.2 NR <1 Any (17% over 18) OR
Table 1. Description of studies included in the meta-analysis. Country: country where data were collected; 
Sample: abbreviated name of the sample originating the data; % medicated: percentage of medicated individuals 
with ADHD, duration is duration of follow-up time for occurrence of injuries and is reported as <1 (less or 
equal to a year) or >1 (more than a year); Age range at injury; NR: not reported; NA: not applicable. aObtained 
from biggest outcome. bEstimated from total (3.5% of total for individuals with ADHD and 96.5 for individuals 
without ADHD)69. cNumber obtained from article(s) reporting poisoning. dAveraged between outcomes.
Name Method for diagnosis Classification system(s): codes Types of poisoning
Brehaut (2003)22 Registry ICD-9: 960–989 Medicinal and non-medicinal
CPRD-HES: Prasad (2016)23 Registry ICD-10 and OPCS4 Medicinal and non-medicinal
Hariharan (2008)21 Registry ICD-9 Medicinal (self-taken, not inhaled or by contact).
Hurtig (2016)24 Registry ICD-8, ICD-9 and ICD-10 Medicinal and non-medicinal
LHID: Tai (2013)20 Registry ICD-9: 960–989 Medicinal and non-medicinal70
LHID: Chou (2014)25 Registry ICD-9: 960–979 and E930–949 Medicinal (deliberate)
Lindemann (2017)26 Registry ICD-10 T36–75, T96–97 System-wide injuries71
Rowe (2004)27 Self-report NA Medicinal and non-medicinal
Silva (2014)28 Registry ICD-9 and ICD-10: T36-T65 Medicinal and non-medicinal
Swensen (2004)29 Registry ICD-9: 960–989 Medicinal and non-medicinal
Table 2. Identification of poisoning cases. Registry indicates that a retrospective registry was used to identify 
poisoning cases. OPCS4: Office of Population Censuses and Surveys (OPCS-4) version 4. NA: not applicable.
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without the disorder (RR = 3.14, 95% CI- = 2.23 to 4.42) as shown in the forest plot in Fig. 2. Heterogeneity of 
studies, as measured by Cochran’s Q test and I2 index35, was high (χ2 = 49.42, df = 8, p < 0.001, I2 = 83.8%). Risk 
of small sample bias was not significant according to Begg’s adjusted rank correlation and Egger’s test (Egger 
t = −0.07, p = 0.949; Begg Z = 0.52, p = 0.602, see also the funnel plot in Fig. 3).
In general, results were relatively robust to sensitivity analyses. When only studies using hazard ratios as effect 
measure were included, the resulting average RR was 3.91 (95% CI = 3.41 to 4.5, I2 = 0%). The average RR was 
2.59 (95% CI = 1.81 to 3.71, I2 = 64.4%) when only odds ratios were taken into account. Similarly, the pooled 
RR changed to 3.01 (95% CI = 2.01 to 4.50, I2 = 87%) when only statistically adjusted RRs were entered in the 
meta-analysis, and increased to 5.62 (95% CI = 2.51 to 12.61, I2 = 0%) when uncontrolled effect sizes were used. 
Since only two studies did not combine poisoning and intoxication cases (defined using the ICD codes), we 
could not carry out a sensitivity analysis including only studies that focused on a strict definition of poisoning. It 
must be noted that in the case of crude effect sizes and hazard ratios only three and four studies were respectively 
included in the analyses and, therefore, confidence intervals with RVE are unreliable36. Changing the p parameter 
within RVE, a value that accounts for the correlation between outcomes within studies, did not change the previ-
ously stated estimation of effects.
Regarding the risk of bias, ratings on the Newcastle-Ottawa Scale (NOS) tended to be high (range 3 to 6, 
median 5, out of 7 possible stars as 2 items were deemed inadequate for our study). The items of the scale used 
in the present meta-analysis, subscores and total score for each study can be found in Table 4. A meta-regression 
including the NOS37 scores as a regressor showed no significant effects (Beta Coefficient-B- = −0.060, 95% 
CI = −1.087 to 0.967, p = 0.843).
Similarly, the sub-group analyses carried out in order to assess the effect of age were not statistically signifi-
cant: results of the between-studies comparison of outcomes in children under ten years old against outcomes in 
which age was not specified were B = 0.299, 95% CI = −0.404 to 1.000 p = 0.279; when outcomes from partici-
pants with unspecified age were compared to outcomes obtained from participants over 10 years, results were not 
significant (B = −0.417, 95% CI = −0.737 to 1.571 p = 0.185); finally, when outcomes from individuals under and 
above 10 were compared, results were not significant either (B = −0.042, 95% CI = −2.080 to 1.996 p = 0.937).
First author (year) Measure
Description of 
outcome
N non-
ADHD
N 
ADHD
Number 
of non-
ADHD 
poisoned
Number 
of ADHD 
poisoned
Prevalence 
(per 1000) of 
poisoning in 
non-ADHD
Prevalence 
(per 1000) of 
poisoning in 
ADHD
Relative 
Risk LBCI UBCI
Main 
Analysis
Brehaut (2003)22 OR Adjusted 1010067 16806 3882 184 3.8 10.9 2.67 2.27 3.14 Yes
CPRD-HES: Prasad 
(2016)23 HR Adjusted 291909 15742 2033 463 7.0 29.4 3.99 3.58 4.44 Yes
Hariharan (2018)21 OR Unadjusted 87 16 20 11 NR NR 7.98 2.64 24.13 Yes
Hurtig (2016)24 HR
Rating scale, 
injury between 
0 and 6 years. 
Adjusted.
5236 875 44 14 8.4 16.0 1.51 0.76 3.01 Yes
Hurtig (2016)24 HR
Rating scale, 
injury between 
7 and 15 years. 
Adjusted
5639 472 27 9 4.8 19.1 3.42 1.46 8.02 Yes
Hurtig (2016)24 HR
Clinical criteria, 
injury between 
7 and 15 years. 
Adjusted
352 105 3 2 8.5 19.0 6.29 0.8 49.35 Yes
LHID: Tai (2013)20 OR Unadjusted 7860 1965 98 30 12.5 15.3 1.23 0.81 1.85 No
LHID: Chou2 (2014)5 HR Unadjusted 36850 3685 29 13 0.8 3.5 4.51 2.35 8.68 No
LHID: Chou (2014)25 HR Adjusted. 36850 3685 29 13 0.8 3.5 4.65 2.41 8.94 Yes
LHID: Chou (2014)25 OR Unadjusted 36850 3685 29 13 0.8 3.5 4.50 2.33 8.65 No
LHID: Chou (2014)25 HR 0 to12 years. Adjusted. NR NR 29 13 NR NR 2.42 0.99 5.89 No
LHID: Chou (2014)25 HR 12 to 18 years. Adjusted. NR NR 29 13 NR NR 17.86 5.23 61.02 No
Lindemann (2017)26 HR Adjusted 37650 37650 NR NR NR NR 3.47 2.14 5.64 Yes
Rowe (2004)27 OR Psychiatric model. Adjusted NR NR NR NR NR NR 1.2 0.5 2.6 Yes
Silva (2014)28 OR Adjusted 8896 5363 332 322 37.3 60.0 2.24 1.91 2.65 Yes
Swensen (2004)29 OR Unadjusted 1308 1308 5 22 3.8 16.8 4.46 1.68 11.81 Yes
Table 3. Outcome-level details of all the outcomes extracted from the studies included in the risk of poisoning 
analyses. N: number of individuals in each group; OR: odds ratio between children and adolescents with 
ADHD and without ADHD; HR: hazard ratio between children and adolescents with ADHD and without 
ADHD; LBCI: lower bound of the 95% confident interval; UBCI: upper bound of the 95% confident interval; 
Main analysis: it indicates if the outcome has been included in the main analysis (most controlled and general 
outcome) and in the main sensitivity analyses. NR: not reported.
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Figure 2. Pooled effect size estimating the association between ADHD and poisoning. Hazard and odds ratios 
were combined. The area of each square is proportional to the weight that the individual study contributed to 
the meta-analysis. Weights are from a ramdom-effects model using RVE. The diamond indicates the overall 
weighted mean effect across all studies. Study name is the first author and year except when several articles 
come from the same database. RR: relative risk, UBCI: upper bound of the 95% confidence interval, LBCI: lower 
bound of the 95% confidence interval
Figure 3. Funnel plot of the studies included in the risk of poisoning meta-analysis.
Name NOS version
Selection (up 
to 3 stars)a
Comparability(up 
to 2 stars)
Outcome/Exposure 
(up to 2 stars)a
NOS total (up 
to 7 stars)
Brehaut22 Cohort 2 1 1 4
CPRD-HES: Prasad23 Cohort 3 1 1 5
Hariharan21 Case-control 1 1 1 3
Hurtig24 Cohort 2.5* 1 1 4.5
LHID20,25 Cohort 3 1 1 5
Lindemann26 Cohort 3 1 1 5
Rowe27 Cohort 3 2 0 5
Silva28 Cohort 3 1 1 5
Swensen29 Cohort 3 2 1 6
Table 4. Newcastle Ottawa Scale scores. Number of stars for each subsection of the Newcastle-Ottawa 
Scale (NOS) and the total score. aAn item from the original scale was not relevant for our meta-analysis (see 
Supplementary Material, S3 Methods). *Averaged between outcomes.
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An important question of our systematic review and meta-analysis was whether the relative risk of poisoning 
was statistically different from the relative risk of suffering physical injuries in general. In order to answer this 
question, we extracted effect sizes reporting the relative risk of unintentional injuries from studies that reported 
both. Eight studies reported outcomes for both poisoning and physical injuries and one study21 reported only 
poisoning outcomes. The outcomes related to physical injuries (10 in total) are summarized in Table S3 (see sup-
plementary material). The pooled RR of physical injuries was 1.54 (95% CI = 1.33 to 1.78). Heterogeneity of stud-
ies was significant (χ2 = 64.72, df = 7, p < 0.001, I2 = 89.2%). Risk of small sample bias was not significant (Egger 
t = −0.27, p = 0.798; Begg Z = 0.37, p = 0.711). The relative risk of physical injuries was significantly smaller than 
the one in the case of poisoning (B = 0.686, 95% CI = 0.166 to 1.206, p = 0.021). A forest plot comparing the two 
combinations of outcomes, with effect measures from studies which reported both physical injuries and poison-
ing outcomes, is shown in Fig. 4.
The confidence intervals of the pooled estimates of physical injuries reported in the present meta-analysis 
(ES = 1.54, 95% CI = 1.33 to 1.78, derived from the combination of studies that also reported estimates of poison-
ing), and those in our previous article (ES = 1.53, 95% CI = 1.40 to 1.67, derived from any study reporting inju-
ries), did not overlap with the confidence intervals for the overall effect of poisoning (ES = 3.14, 95% CI = 2.23 
to 4.42)17. The same occurred when the analysis was limited to studies reporting hazard ratios, as the confidence 
intervals reported in our previous article for the pooled estimates of physical injuries (HR = 1.39, 95% CI = 1.06 
to 1.83) did not overlap with the confidence intervals for the overall effect of poisoning (HR = 3.91, 95% CI = 3.41 
to 4.40)17. This is further evidence to support that the relative risk of poisoning is significantly greater than the 
relative risk of suffering physical injuries in children and adolescents with ADHD.
Discussion
Poisoning is an important cause of morbidity among children and adolescents worldwide. Children with ADHD 
may represent a particularly vulnerable group, but so far, no pooled estimates of this risk were available. The 
present meta-analysis has concluded that there is a significantly higher risk of poisoning in children and adoles-
cents with ADHD compared with their non-ADHD peers, with an estimated relative risk of 3.14 (95% CI = 2.23 
to 4.42). Taking into account the prevalence of ADHD, the disorder could be a major factor contributing to the 
overall number of pediatric poisonings. Results derive from the combination of nine large population-based stud-
ies with a combined sample close to 1.4 million children and adolescents from the general population and 85k 
individuals with ADHD. The confidence interval of the estimate is quite narrow (95% CI = 2.23 to 4.42) because 
of the large sample size.
This increased risk is consistent with previous research, showing a significantly higher risk of physical injuries 
in individuals with ADHD38. Specific features of the disorder such as impulsivity and inattention are likely a 
Figure 4. Comparison between the relative risk of poisoning and that of physical injuries in ADHD. Hazard 
and odds ratios from studies which reported both physical injuries and poisoning outcomes were combined. 
Poisoning relative risks are shown in blue and relative risks of physical injuries in red. Study name is the first 
author and year, except when several articles come from the same database. RR: relative risk, UBCI: upper 
bound of the 95% confidence interval, LBCI: lower bound of the 95% confidence interval. p value is obtained 
from a within-study analysis and indicates that the relative risk of poisoning is greater than that of physical 
injuries in children and adolescents with ADHD compared to their peers.
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major risk factor for poisoning. Our work provides solid meta-analytic evidence further highlighting that ADHD 
is a disorder with consequences that are not limited to the behavioral or educational domains. It has an impact 
on different health aspects39 and hence, leads to a reduction in the overall quality of life of the patients and their 
families14.
Results were generally robust to different sensitivity analyses. Furthermore, there was no statistical indication 
of small-sample bias, including publication bias. However, these analyses were limited by the final number of 
outcomes and studies in our meta-analysis, so that our results could partly reflect a lack of statistical power. A 
possible qualitative interpretation of the funnel plot related to our analyses is that studies with greater standard 
errors (typically smaller studies) were more likely published if they showed an increased risk of poisoning in chil-
dren/adolescents with ADHD. If real, hidden reporting bias could be leading to an overestimation of the overall 
effect. However, a line of evidence makes this overestimation unlikely. In most published studies, relative risk of 
poisoning was only a secondary outcome among several other subgroups of injuries, whereas the central finding 
of these studies was an overall increased risk of injuries. In such case, publication bias due to results of only one 
of many secondary outcomes is unlikely. Moreover, within study comparisons are robust to publication biases. If 
there was an overall publication bias towards a higher risk of injuries in ADHD (and not only of poisoning), our 
within-study analytic strategy demonstrating that the relative risk of poisoning is greater than the relative risk of 
physical injuries in general would not be affected.
As already mentioned, whereas the pooled sample in our meta-analysis was very big, the number of studies 
was limited. This can be explained by the fact that poisoning cases are a rare event and, therefore, very large 
databases are typically needed to be able to carry out epidemiological studies on this outcome. These large epi-
demiological studies are difficult to conduct: on the one hand, prospective cohorts are expensive and limited; on 
the other hand, administrative databases (that is, databases for which the main aim and design was not initially 
research)34 are also limited in number and in many cases will not include measures of interest for the specific 
research question. Both issues, number of studies and measures reported in them, limited our analyses. We were 
not able to carry out possibly informative regression analyses, such as evaluating a relationship between the risk 
of poisoning and ADHD symptoms, or controlling for comorbidity. Similarly, the statistical power of our regres-
sion analyses was also very low. Indeed, as it is always the case in frequentist statistics, a lack of significance only 
indicates that there is not enough evidence for an effect, which does not necessary involve that there is not such an 
effect. Given that our statistical power was limited due to the characteristics of existing research, our results leave 
an open door for future studies evaluating such effects.
It is also noteworthy that despite our strict inclusion criteria, heterogeneity among studies was significant. 
Heterogeneity was dealt through the use of random-effects models that assume that the true effect size might 
differ from study to study, and that studies included in the analysis are a random sample of all possible studies that 
meet the inclusion criteria. Additionally, we investigated the origins of heterogeneity through meta-regression. 
The most influential factor driving heterogeneity was the type of outcome measure (Hazard or odds ratios), which 
influenced not only the pooled effect size (RR = 3.91, 95% CI = 3.41 to 4.5 for HR; RR = 2.59, 95% CI = 1.81 to 
3.71 for OR) but also the I2 statistic (64.4% when only OR were included and 0% when only HR were included). 
However, this difference between results cannot be explained by the different outcome measure per se but from 
other study characteristics that co-occur with the selection of the outcome measure. Taking into account the fact 
that studies reporting HR tended to be larger, more representative of the population, had better statistical control 
of possible confounders, and the heterogeneity of their results was smaller, the estimation obtained when only 
including HR studies might better reflect the true relative risk of poisoning in children and adolescents with 
ADHD. It must be noted, however, that only four studies were included in the case of HRs and hence the confi-
dence intervals calculated through RVE could be wider than expected36.
An additional major finding of the meta-analysis is that the relative risk of poisoning in individuals with 
ADHD compared to individuals without it was statistically higher than the overall relative risk of physical inju-
ries. Eight studies reported both injuries in general and poisoning cases, hence permitting a within-study eval-
uation of the effect of type of injury. Of note, the risk of injuries from the combination of the eight studies was 
1.54 (95% CI = 1.33 to1.78), closely matching the results from our previous meta-analysis on the risk of physical 
injuries, in which the mean RR was 1.53 (95% CI = 1.40 to 1.67). Several factors could be accounting for this 
increased relative risk. Accidental overdoses due to a difference between the taken and prescribed doses are com-
mon in pediatric populations40, and they increase with an easier access to pharmacological drugs. Indeed, access 
to medications has been reported as a risk factor for unintentional poisoning41,42. Children and adolescents with 
ADHD have more access to medications than developmentally normal individuals do. Nearly 60% of ADHD 
diagnosed children receive pharmacological treatment with stimulants and other drugs43,44, and in many cases a 
single individual will be prescribed several formulations of the same medication45. In addition, many individuals 
will receive additional medications for comorbid disorders16, such as oppositional defiant disorder, conduct disor-
der, anxiety, coordination problems, depression, tic disorders and Tourette syndrome. Hence, the poly-pharmacy 
status in many ADHD patients could increase the likelihood of an accidental poisoning. Moreover, comorbid 
mental disorders might make children and adolescents with ADHD even more prone to an accidental poisoning. 
Data on comorbidity was not reported in most of the studies included in the present meta-analysis, so that the 
impact of comorbidity could not be elucidated. Further research should clarify whether medicated individuals are 
at a greater risk of poisoning, if comorbidities increase the risk of intoxications, and to which extent these effects 
can be disentangled. The role of ADHD medication is even more complex. ADHD pharmacological treatment 
has already been shown to reduce the risk of suffering an unintentional injury17, and conversely, it reduces the 
risk of driving accidents in adults46,47. Drugs used to treat ADHD could have a similar effect on the risk of poising: 
as they improve attention and impulsivity, they could lead to a reduction in the risk of poisoning. However, our 
systematic review was not able to find any studies on the effect of medication on poisoning risk. Therefore, the 
relationship between medication effects and risk of poisoning in ADHD deserves further clarification.
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In terms of age effects, poisoning incidence has two peaks across the child life span. The first peak occurs in 
the first years of life and the second is around the beginning of adolescence, changing also the causal factors of 
poisoning1,5. As the child grows, there is an increase of intentional poisonings, although the total percentage of 
intentional poisonings remains lower than the percentage of unintentional cases1,5. For the second age group, 
recreational drug usage and suicide attempts are important causes of poisoning. Regarding the specific case of 
individuals with ADHD, adolescents with the disorder use more frequently drugs recreationally48, including 
their own medications49. For example, a study carried out among adolescents and young adults with the dis-
order reported that 14.3% of the participants in the study had once abused of their prescribed pharmacological 
treatment50. Furthermore, evidence tends to support the fact that individuals with ADHD have a higher risk of 
suicide and suicide attempts19. In summary, ADHD adolescents could be especially prone to intentional (suicide 
attempts) or semi-intentional (recreational drug use) cases of poisoning, compared to younger children with the 
disorder and also the general population, and this could be driving in part the higher risk of poisonings compared 
to physical injuries. However, a direct test of this hypothesis was not possible in our meta-analysis since included 
studies did not differentiate between intentional and unintentional poisonings. Whereas future studies should try 
to address this issue, it must be noted that this differentiation is likely impossible when using administrative data-
bases. We sought for indirect support for the role of intentional poisoning through a meta-regression including 
age as a covariate, but the results of this meta-regression analysis were not significant. Therefore, the role of age as 
a mediator in this issue still remains unknown.
The results of our systematic review/meta-analysis should be considered in the light of its strengths and lim-
itations. As for the strengths, we pre-registered the protocol in a publicly available repository (PROSPERO), 
reducing the risk of reporting bias. Furthermore, we endeavored to perform a comprehensive and systematic 
search in several databases, with no restrictions in terms of language, date, or document type. Additionally, we 
used a state-of-the-art tool, the Newcastle-Ottawa scale, to assess the quality of the retained studies. Furthermore, 
the included studies typically used big longitudinal or administrative cohorts or national surveys, which provide 
adequate statistical power to estimate the overall incidence of an infrequent type of event, such as is poisoning. 
There are also a number of limitations that should be taken into account, which are mostly related to the individ-
ual studies that we included rather than to methodological issues with our systematic review/meta-analysis. First, 
intentionality of poisoning was not controlled in the included studies. Second, we could not find sufficient data 
to evaluate the effects of age, medication status or comorbidities on the risk of poisoning in ADHD. Since these 
major confounders were not controlled for in our analyses, the increased relative risk cannot be directly ascribed 
to ADHD. Although our results support the conclusion that individuals with ADHD in the real world suffer more 
poisoning events than those without it, we cannot know what factor or factors are at the origin of this relationship 
and in this regard, any causative explanation derived from them should be taken with caution.
Our findings have important implication from a public health standpoint. Poisoning remains a leading cause 
of preventable injuries in childhood and adolescence1, whose treatment involves a huge cost of economic and 
human resources51,52. The present meta-analysis has shown that children and adolescents with ADHD are a popu-
lation with an increased risk of poisoning. Specific preventive measures in this population could help to minimize 
this risk or the detrimental consequences of poisoning. Health providers should ensure a correct understanding 
of treatment dosages and frequency intakes, as well as alarm signs regarding side effects or poisoning and how 
should parents and or patients act in a case of possible poisoning. They should also emphasize the hazard of hav-
ing dangerous household products out of the reach of children. Further studies on the incidence of intentional 
injuries (recreational drug use and suicide intents) in this population, and the effect of medication on the risk of 
poisoning are needed.
Methods
The Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P)53,54, the Preferred 
Reporting Items for Systematic Review and Meta-Analysis (PRISMA)55,56 and the Meta-analysis of Observational 
Studies in Epidemiology (MOOSE)57 guidelines were followed when planning and carrying out our work. The proto-
col for the study was registered in the international prospective register of systematic reviews held by the University 
of York (PROSPERO) prior to data analysis (registration number CRD42017079911). Methods reflected those of our 
previous meta-analysis on the risk of physical injuries in order to make results comparable58.
Three major databases –PubMed (Medline Plus), Web of Science core database and Scopus- were searched. 
Furthermore, we searched over 110 additional databases from an institutional reference aggregator (UNIKA: 
http://www.unav.edu/en/web/biblioteca), that uses the EBSCO discovery service (http://support.ebsco.com/help/
index.php?lang=en&int=eds) to provide a list of references combining both internal (library) and external (data-
base vendors) sources. Searches were carried out on November 30th 2017, with no time or language restrictions. 
References of retrieved pertinent papers were scanned to find additional possibly relevant studies. References 
of interest from our previous meta-analysis on the risk of physical injuries were also evaluated for potential 
inclusion17. See additional details, including search syntax, in Supplementary Methods 1 and 2 (Supplementary 
material).
Study selection. Study type. Data from published or unpublished empirical studies that compared the risk 
of poisoning in children and/or adolescents with ADHD and in typically developing individuals were combined 
regardless of the design, the temporality (i.e., prospective, retrospective or cross-sectional) or setting (clinical or 
epidemiological).
ADHD diagnosis is more common in males59 and, similarly, poisoning injuries occur more frequently in 
males than in females1. Therefore, we included only articles that took into account this bias either by sample 
selection (no differences in the number of male and females between the ADHD and no ADHD samples) or 
statistically (sex controlled as a confounding covariate).
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Population. The majority of the sample of a study had to be children and/or adolescents (defined as less than 18 
years-old). The accepted operational definitions of ADHD were the following: (1) A categorical diagnosis according 
to standardized criteria, either the DSM (III, III-R, IV, IV-TR or 5) or the diagnosis of hyperkinetic disorder as per 
ICD-10 or previous versions; (2) Being above a pre-established threshold in a validated psychometric scale for the 
screening of ADHD; (3) The coding of the diagnosis in a medical registry; (4) A positive answer to the question: 
“Have you ever been told by a doctor that you have ADHD?” or similar questions; and (5) Being prescribed ADHD 
medication(s). Studies on preschoolers and those using the diagnosis of “Deficits in attention, motor control, and 
perception” (DAMP)60, or equivalent constructs61, were excluded, since they are not equivalent to ADHD.
Outcomes. The World Health Organization (WHO) definition of poisoning or intoxication was used to define 
eligible outcomes. Intoxication is defined by WHO as “a condition that follows the administration of a psychoac-
tive substance and results in disturbances in the level of consciousness, cognition, perception, judgment, affect, 
or behavior, or other psychophysiological functions and response”1. Since the term “intoxication” can be used in 
relation to alcohol or drug abuse, outcomes describing poisoning were preferred to those reporting intoxications. 
However, if an article only reported intoxications, it was also included. Hence, outcomes from articles reporting 
health problems related to the codes T36-T61 of the 19th chapter of the International Classification of Diseases 
(ICD-10) or similar problems were deemed eligible.
Poisoning cases had to be attended at medical settings and a registry created or self-reported. Studies report-
ing information requests to poison information centers or similar entities were not included. Poisoning could 
occur before or after the diagnosis of ADHD. Risk measures had to describe the ratio in the risk of poisoning 
between children and adolescents with and without ADHD. The primary outcome measure was defined as the 
hazard ratio (HR) obtained from Cox proportional hazards models, as it provides a time-independent estimation 
of the risk. However, odds ratios (ORs) are more frequently reported than HR, and they are the only risk measure 
that can be obtained from case-control studies that compare ADHD rates in a poisoned and a non-poisoned 
group. Therefore, ORs were accepted as secondary valid estimations of relative risk and combined with HRs.
In order to address the secondary aim of the present meta-analysis (i.e., assess if there is a significantly higher 
relative risk of poisoning compared to the relative risk of suffering other physical injuries), studies which reported 
outcomes on the relative risk of physical injuries in general and also provided similar data on the relative risk of 
poisoning were eligible.
Identification and selection of studies. Studies were identified and selected following a two-stage pro-
cess: (1) Two investigators independently and blindly screened retrieved titles and abstracts of all non-duplicated 
papers to exclude non-pertinent ones. Discrepancies were resolved by consensus; (2) Articles carried to this stage 
were assessed after reading the full-text following a similar process of double evaluation similar to the one of the 
previous step. Multiple reports of the same study were linked together.
Data extraction. M.R.-G. and G.A. independently extracted data from articles that had been deemed eligi-
ble in the selection stage.
A modified version of the Newcastle-Ottawa Scale (NOS)37 was used to assess the risk of bias of each study 
and rated independently by the same authors. Any discrepancies at this stage were resolved by consensus between 
M.R.-G. and G.A. Two items, one in the selection and one in the exposure subsections, were eliminated as they 
were deemed inadequate for our study. Hence, the maximum score in the scale was seven instead of nine stars. 
Final items of the scale can be found in Supplementary Methods 3 in supplementary material.
Data synthesis. Summary effect measures (HRs or ORs) were combined in order to estimate a population-average 
relative risk between ADHD and poisoning in children and adolescents. Hazard Ratios and Odds Ratios were consid-
ered equivalent measures of relative risk as the baseline prevalence of poisoning was expected to be very low (less than 
1%). In such cases the two measures yield very close results62,63.
Robust Variance Estimation64,65, a statistical technique that models the nested structure between outcomes 
of the same study and allows to account for the non-independence of outcomes, was used for the inference of 
a mean effect size and meta-regression analyses. We carried out a mixed-effect model with robust variance and 
random-effect estimates. A model with variation of RRs between studies and equicorrelation between same-study 
effect sizes (p; p = 0.8 in this case) was assumed. This strategy is highly efficient to estimate a mean model from 
outcomes which are typically correlated at the study level, but are usually independent between studies64. The 
influence of the equicorrelation value chosen here, the most commonly used in previous studies65,66, was evalu-
ated in a sensitivity analysis with varying levels of p (0.1 steps between 0 and 1).
Cochran’s Q test and I2 index35 were used to evaluate heterogeneity among studies, whereas Begg’s adjusted rank 
correlation and Egger’s test were implemented to formally assess the presence of “small-sample” bias. These analyses 
were carried out using a single outcome per study. This outcome was selected at random whenever more than one 
existed. We planned to combine all outcomes fulfilling our inclusion criteria independently of the results of hetero-
geneity analyses and deal with heterogeneity through the use of a random-effects model and meta-regression, as the 
exclusion of studies prior to performing a meta-analysis affects the validity of the subsequent results67. Additional 
sensitivity/subgroup analyses consisted in: 1-Including ORs and HRs in separate analyses; 2-Calculating a mean 
effect size including only statistically unadjusted outcomes (from studies that, at least, controlled for sex by design); 
3-Calculating a mean effect size including only adjusted outcomes (controlled covariates could include sex. If this 
was not the case, sex was controlled through sample selection); 4-Evaluating the influence of removing articles that 
report intoxication risk (instead of poisoning); 5-Investigating the influence of the risk of bias as evaluated by the 
rating in the Newcastle-Ottawa Scale by carrying out a meta-regression analysis with the number of stars on the scale 
for each article as a predictor. We also investigated the effect of age on the risk of poisoning by splitting outcomes into 
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3 groups according to the age distribution of the participants: outcomes in which participants were under the age of 
10, outcomes that included individuals of any age and outcomes in which participants were between 11 and 18 years 
old. The three groups of outcomes were compared pair-wise using a between-study meta-regression model as we 
hypothesized that the risk of poisoning would be significantly greater in the older group when compared to younger 
individuals or to individuals of all ages.
Finally, we investigated whether, compared to those without, children/adolescents with ADHD had a sig-
nificantly higher risk of poisoning than of suffering other kinds of physical injuries. To this end, in order to 
control for confounding variables which could affect this comparison (i.e. country of origin and socio-cultural 
background of participants), only studies that reported both outcomes (effect measure of poisoning and of suf-
fering physical injuries) were evaluated. These two groups of outcomes were compared using a within-study 
meta-regression model64,65. This analysis is optimal in cases where there exists within-studies variability in the 
covariate (outcome type in our case). This variability is studied by including the distance value around the study 
regressor mean as a covariate in the regression model68.
Effect sizes whose 95% confidence intervals (CIs) did not include 1 were considered significant. Analyses were 
carried out in STATA v13. Forest plots were created using the DistillerSR Forest Plot Generator from Evidence 
Partners (https://www.evidencepartners.com/resources/forest-plot-generator/).
Data statement. All data used in the preparation of the systematic review and meta-analysis is available 
upon request.
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